BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Capsida Biotherapeutics

Capsida Biotherapeutics logo

Founded
2019
Geography
United States of America based

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.


Posts Mentioning This Company

R&D Platform

Current gene therapy approaches have shown dramatic efficacy in several rare diseases but are hindered by imprecise targeting. The inability to selectively transduce specific cells and tissues effectively drives administration of higher doses and resulting safety liabilities. We are addressing these concerns with our proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the disease organ while limiting transduction of tissues and cells not relevant to the target disease.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet